Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Símbolo desconocido
Fecha:
Ordernar por:
FechaHoraFuenteTítuloSímboloCompañía
18/07/202400:21PR Newswire (US)GameFi + DePIN: Japanese Web3 Organization Rona Redefines Next-Generation Consoles
18/07/202400:19PR Newswire (US)MicuRx Presents Innovative Antibiotic Research Results at the 7th World Bronchiectasis Conference
18/07/202400:08NEWSBTCCardano (ADA) Could Retrace Gains, Yet the Bullish Trend PersistsCOIN:TRXUSDTRON
18/07/202400:05CointelegraphLMBO and REKT: Direxion debuts leveraged ETFs tracking crypto equitiesCOIN:BTCUSDBitcoin
18/07/202400:00NEWSBTCXRP Surges 39% As Sharks & Whales Push Supply Share Past 85%COIN:QNTUSDQuant
18/07/202400:00Business WireMon Courtier Energie Groupe Announces H1 2024 Revenue Growth of +13% to €11.9mEU:ALMCEMon Courtier Energie Groupe SA
18/07/202400:00GlobeNewswire Inc.argenx to Report Half Year 2024 Financial Results and Second Quarter Business Update on July 25, 2024EU:ARGXArgen X SE
18/07/202400:00Business WireGroupe Berkem annonce la signature d’un traité d’apport et la conclusion d’un protocole d’investissement entre son principal actionnaire et Eurazeo en vue d’un projet d’offre publique d’achat simplifiéeEU:ALKEMGroupe Berkem SA
18/07/202400:00GlobeNewswire Inc.Nokia Corporation Report for Q2 and Half Year 20240HAF
18/07/202400:00Business WireMon courtier énergie groupe annonce une croissance de +13% à 11,9 M€ de son chiffre d’affaires au 1er semestre 2024EU:ALMCEMon Courtier Energie Groupe SA
18/07/202400:00Business WireGroupe Berkem Announces the Signature of a Contribution Agreement and the Conclusion of an Investment Agreement Between Its Main Shareholder and Eurazeo in View of a Simplified Tender Offer ProjectEU:ALKEMGroupe Berkem SA
18/07/202400:00PR Newswire (US)Renalys Pharma announces first patient dosed in registrational Phase III clinical trial of sparsentan for IgA nephropathy in Japan
17/07/202423:50Alliance NewsAlliance NewsGLOBAL BRIEFING: Japan returns to trade surplus on weaker imports
17/07/202423:48PR Newswire (US)BSI receives ISO 37001 certification from Speeki Europe
17/07/202423:24CointelegraphAnthropic partners with Menlo for $100M fund investing in AI startupsCOIN:BTCUSDBitcoin
17/07/202423:20PR Newswire (US)PairX Bio Clinches Coveted Amgen Golden Ticket Award, as NSG BioLabs Deepens Efforts with Partners CapitaLand and Amgen to Boost Singapore's Biotech Ecosystem with Fourth Site and Extended Awards Programme
17/07/202423:16Business WireAxelspace kündigt neuen Service „AxelLiner Laboratory (AL Lab)“ an, um den rasant wachsenden Bedarf an In-Orbit-Demonstrationen von Weltraumkomponenten zu decken
17/07/202423:08NEWSBTCXRP Price Regains $0.60: Key Levels to Watch Moving ForwardCOIN:ETHUSDEthereum
17/07/202423:08Business WireAkasa Air Commences Operations from Jeddah; and Strengthens Its Presence in the Kingdom of Saudi Arabia
17/07/202423:02PR Newswire (US)2024 MITSUBISHI OUTLANDER HAS YOUR BACK WITH A HOST OF SAFETY FEATURES
17/07/202423:01PR Newswire (US)Quantum Computing On Track to Create Up to $850 Billion of Economic Value By 2040
17/07/202423:01GlobeNewswire Inc.Most small SUVs perform well in rear autobrake evaluation
17/07/202423:00PR Newswire (US)Urgent Revelation: Psychology Originated Within Christian Theology, Not As A Secular Discipline
17/07/202423:00PR Newswire (US)OKX Ventures Announces Investment in zkLink to Unify Liquidity with Aggregated Rollups
17/07/202423:00PR Newswire (US)God Has a Plan For Every Living Creature: Who Will Rise Up, Reach Out, and Follow God's Plan to Fruition?
17/07/202423:00PR Newswire (US)Mercy Medical Center Gastroenterologist Dr. Raymond K. Cross Elected to American College of Gastroenterology's Board of Governors
17/07/202423:00PR Newswire (US)Action-Packed Christian Fiction Takes Readers on a Relatable Journey of Navigating Fears
17/07/202422:38GlobeNewswire Inc.Junshi Biosciences Announces the Acceptance of the Supplemental New Drug Application for Toripalimab Combined with Bevacizumab for the First-Line Treatment of Advanced Hepatocellular Carcinoma
17/07/202422:36Business WireErgBot Acquired by Power Ten Metrics in Agreement Between Rowing Technology Companies
17/07/202422:30NEWSBTCCrypto Analyst Predicts 450% Move For Shiba Inu To Reach New All-Time HighCOIN:OPUSDOptimism